The FDA has approved the Elecsys pTau181 test to assist in the initial assessment for Alzheimer's disease and other causes of ...

The global Phospho-specific Antibodies Market is on a dynamic growth trajectory, poised to expand from USD 29.3 billion in ...

Newborn babies and patients with Alzheimer's disease share an unexpected biological trait: elevated levels of a well-known biomarker for Alzheimer's. This is shown in a study led by researchers at the ...

The test uses mass spectrometry to measure several proteins to assess the likelihood that an individual has the brain amyloid pathology associated with Alzheimer's disease.

Assessing pathological synuclein in simple skin biopsies can take the place of more invasive diagnostic procedures. Diagnosing neurodegenerative conditions called synucleinopathies, particularly in ...